Antitumor Effects of L-citrulline on Hela Cervical Cancer Cell Lines
Open Access
- 14 September 2022
- journal article
- research article
- Published by Bentham Science Publishers Ltd. in Anti-Cancer Agents in Medicinal Chemistry
- Vol. 22 (18) , 3157-3162
Abstract
Introduction: Cervical cancer is the deadliest gynecological malignancy. This study aims to examine the anticancer effects of L-citrulline on HeLa cell culture. Materials-Methods: HeLa cells were cultured in complete Eagle's minimum essential medium. HeLa cells were seeded in 96-well plates and incubated with L-citrulline. After incubation, MTT dye was added and incubated. Annexin- V technique was used to test the apoptosis. The activated caspases of HeLa cells by L-citrulline exposure were measured with the Caspase 3/7 technique. One-way variance analysis was conducted for statistical analysis by using GraphPad Prism 6.0 for Windows. Results: L-citrulline showed its toxicity on HeLa cells in a dose-dependent manner in application times of 24 and 48 hours. The IC50 dose of L-citrulline was 0.19 and 0.16 mg/mL at 24 and 48 hours, respectively. When HeLa cells were exposed to an IC50 dose of L-citrulline for 24 hours, the percentages of the dead, early apoptotic, and late apoptotic cells were detected to be 0.75%, 23.05%, and 12.75%, respectively. The differences in the wideness of the scratch area were observed at the initial stage and after 24 hours of applying L-citrulline. Conclusion: L-citrulline showed its toxicity on HeLa cells in a dose-dependent manner. Based on Annexin and Caspase findings, it can be concluded that L-citrulline exerted a pro-apoptotic effect on HeLa cells in only a short exposure time. L-citrulline also showed a migration inhibitory effect. The findings of this study indicate L-citrulline to be worthy of investigation for its anticancer activities in vitro and in vivo, and as a candidate for cancer therapy.Keywords
This publication has 31 references indexed in Scilit:
- Citrulline: From metabolism to therapeutic useNutrition, 2013
- Modified Annexin V/Propidium Iodide Apoptosis Assay For Accurate Assessment of Cell DeathJournal of Visualized Experiments, 2011
- Optimization of the Tetrazolium Dye (MTT) Colorimetric Assay for Cellular Growth and Viability2011
- The role of tumor initiating cells in drug resistance of breast cancer: Implications for future therapeutic approachesDrug Resistance Updates, 2010
- Cellular resistance to a nitric oxide releasing glutathione S-transferase P-activated prodrug, PABA/NOInvestigational New Drugs, 2010
- Understanding the causes of multidrug resistance in cancer: a comparison of doxorubicin and sunitinibDrug Resistance Updates, 2009
- Novel therapeutic applications of nitric oxide donors in cancer: Roles in chemo- and immunosensitization to apoptosis and inhibition of metastasesNitric Oxide, 2008
- Selective opening of the blood—brain barrier by a nitric oxide donor and long-term survival in rats with C6 gliomasJournal of Neurosurgery, 2003
- Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell killJournal of Immunological Methods, 1989
- An improved colorimetric assay for interleukin 2Journal of Immunological Methods, 1986